A comparison of generic drug prices in seven European countries: a methodological analysis
Abstract Background Policymakers and researchers frequently compare the prices of medicines between countries. Such comparisons often serve as barometers of how pricing and reimbursement policies are performing. The aim of this study was to examine methodological challenges to comparing generic drug...
Saved in:
Main Authors: | Olivier J. Wouters (Author), Panos G. Kanavos (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
by: Bregtje W. Kamphuis, et al.
Published: (2021) -
Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries
by: Mackenzie Mills, et al.
Published: (2023) -
Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework
by: Panos Kanavos, et al.
Published: (2015) -
Comparison of Cardiovascular Medicines Prices in Four European Countries
by: Zornitsa Mitkova, et al.
Published: (2020) -
Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals - comparison of Austria and Finland
by: Jaana E Martikainen, et al.
Published: (2015)